vs
Side-by-side financial comparison of BrightSpire Capital, Inc. (BRSP) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
BrightSpire Capital, Inc. is the larger business by last-quarter revenue ($83.2M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). BrightSpire Capital, Inc. runs the higher net margin — -17.3% vs -38.1%, a 20.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -6.8%).
Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
BRSP vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.2M | $83.1M |
| Net Profit | $-14.4M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | -17.3% | -38.1% |
| Revenue YoY | -0.4% | 20.2% |
| Net Profit YoY | 27.3% | -27.9% |
| EPS (diluted) | $-0.11 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $83.2M | $76.4M | ||
| Q3 25 | $83.9M | $83.3M | ||
| Q2 25 | $85.9M | $79.2M | ||
| Q1 25 | $77.6M | $69.2M | ||
| Q4 24 | $83.5M | $68.2M | ||
| Q3 24 | $88.2M | $58.4M | ||
| Q2 24 | $91.4M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-14.4M | $-29.8M | ||
| Q3 25 | $984.0K | $-21.4M | ||
| Q2 25 | $-23.1M | $-19.6M | ||
| Q1 25 | $5.3M | $-24.7M | ||
| Q4 24 | $-19.7M | $-18.9M | ||
| Q3 24 | $12.7M | $-21.0M | ||
| Q2 24 | $-67.9M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | -1.7% | -27.8% | ||
| Q2 25 | -54.5% | -28.0% | ||
| Q1 25 | 5.1% | -39.7% | ||
| Q4 24 | -24.9% | -28.9% | ||
| Q3 24 | 13.2% | -38.4% | ||
| Q2 24 | -74.9% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -17.3% | -39.1% | ||
| Q3 25 | 1.2% | -25.7% | ||
| Q2 25 | -26.9% | -24.7% | ||
| Q1 25 | 6.9% | -35.8% | ||
| Q4 24 | -23.7% | -27.6% | ||
| Q3 24 | 14.4% | -35.9% | ||
| Q2 24 | -74.2% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.11 | $-0.54 | ||
| Q3 25 | $0.00 | $-0.38 | ||
| Q2 25 | $-0.19 | $-0.35 | ||
| Q1 25 | $0.04 | $-0.45 | ||
| Q4 24 | $-0.16 | $-0.34 | ||
| Q3 24 | $0.09 | $-0.40 | ||
| Q2 24 | $-0.53 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.8M | $245.6M |
| Total DebtLower is stronger | $2.5B | $51.7M |
| Stockholders' EquityBook value | $938.4M | $347.7M |
| Total Assets | $3.6B | $487.1M |
| Debt / EquityLower = less leverage | 2.63× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $66.8M | $286.5M | ||
| Q3 25 | $113.4M | $294.3M | ||
| Q2 25 | $154.3M | $302.7M | ||
| Q1 25 | $200.9M | $316.2M | ||
| Q4 24 | $302.2M | $333.7M | ||
| Q3 24 | $263.8M | $196.8M | ||
| Q2 24 | $203.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $2.5B | $51.6M | ||
| Q3 25 | $2.2B | $51.6M | ||
| Q2 25 | $2.3B | $51.5M | ||
| Q1 25 | $2.3B | $51.5M | ||
| Q4 24 | $2.5B | $51.5M | ||
| Q3 24 | $2.6B | $51.4M | ||
| Q2 24 | $2.5B | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $938.4M | $365.9M | ||
| Q3 25 | $976.4M | $380.3M | ||
| Q2 25 | $994.4M | $385.8M | ||
| Q1 25 | $1.0B | $389.2M | ||
| Q4 24 | $1.0B | $402.2M | ||
| Q3 24 | $1.1B | $241.2M | ||
| Q2 24 | $1.1B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $3.6B | $508.1M | ||
| Q3 25 | $3.3B | $511.5M | ||
| Q2 25 | $3.4B | $513.1M | ||
| Q1 25 | $3.6B | $519.4M | ||
| Q4 24 | $3.7B | $534.0M | ||
| Q3 24 | $3.8B | $374.1M | ||
| Q2 24 | $3.8B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 2.63× | 0.14× | ||
| Q3 25 | 2.22× | 0.14× | ||
| Q2 25 | 2.27× | 0.13× | ||
| Q1 25 | 2.27× | 0.13× | ||
| Q4 24 | 2.38× | 0.13× | ||
| Q3 24 | 2.36× | 0.21× | ||
| Q2 24 | 2.28× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.0M | — |
| Free Cash FlowOCF − Capex | $55.1M | — |
| FCF MarginFCF / Revenue | 66.2% | — |
| Capex IntensityCapex / Revenue | 21.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $102.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $73.0M | $-10.3M | ||
| Q3 25 | $29.9M | $-6.6M | ||
| Q2 25 | $17.4M | $-15.0M | ||
| Q1 25 | $10.5M | $-17.0M | ||
| Q4 24 | $103.4M | $-32.4M | ||
| Q3 24 | $31.3M | $-18.8M | ||
| Q2 24 | $22.9M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $55.1M | $-12.2M | ||
| Q3 25 | $27.4M | $-9.5M | ||
| Q2 25 | $11.6M | $-17.8M | ||
| Q1 25 | $8.0M | $-18.8M | ||
| Q4 24 | $97.3M | $-33.6M | ||
| Q3 24 | $28.3M | $-19.0M | ||
| Q2 24 | $22.7M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 66.2% | -15.9% | ||
| Q3 25 | 32.7% | -11.4% | ||
| Q2 25 | 13.4% | -22.5% | ||
| Q1 25 | 10.3% | -27.2% | ||
| Q4 24 | 116.6% | -49.2% | ||
| Q3 24 | 32.1% | -32.6% | ||
| Q2 24 | 24.9% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 21.6% | 2.4% | ||
| Q3 25 | 2.9% | 3.4% | ||
| Q2 25 | 6.8% | 3.5% | ||
| Q1 25 | 3.2% | 2.7% | ||
| Q4 24 | 7.3% | 1.7% | ||
| Q3 24 | 3.4% | 0.4% | ||
| Q2 24 | 0.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 30.36× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.46× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRSP
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
